淋病治疗市场 - 增长、趋势、COVID-19 影响和预测 (2023 - 2028)

淋病治疗市场按淋球菌感染、治疗类型(单药和双药)、最终用户和地理位置细分

淋病治疗市场快照

Gonorrhea Therapeutics Market
Study Period: 2018 - 2026
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 3.5 %

Major Players

rd-img

*Disclaimer: Major Players sorted in no particular order

setting-icon

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

淋病是一种由性传播细菌引起的感染,可感染男性和女性。淋病流行率上升、国家筛查计划的实施和公众意识的提高等主要因素正在推动淋病治疗市场的增长。根据疾病控制和预防中心 (CDC) 的数据,每年检测到大约 700,000 例新的淋病病例。2019 年,美国国家过敏症和传染病研究所 (NIAID) 已在五年内拨款 4160 万美元,用于支持对导致梅毒、淋病和衣原体的细菌的多学科合作研究。因此,随着性病的日益流行,通过全国性运动提高了患者的意识,预计政府越来越多的举措将推动市场增长。

然而,与访问性病诊所的患者相关的严格监管情景和社会污名预计将在预测期内抑制全球市场的增长。

报告范围

根据报告的范围,淋病是一种由淋球菌 (Gc) 引起的常见性传播疾病 (STD),如果不及时发现和治疗,会导致严重的并发症。

By Gonococcal Infection
Uncomplicated Gonococcal Infection
Gonococcal Arthritis
Gonococcal Meningitis and Endocarditis
By Treatment
Monotherapy
Dual Therapy
By End User
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East & Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

主要市场趋势

预计双重治疗部门将在预测期内实现良好增长

按治疗,市场已细分为单一疗法和双重疗法。由淋病奈瑟菌引起的淋病是第二常见的细菌性 STI,并导致大量发病率。据估计,双重治疗领域将主导全球市场,预计这一趋势将在预测期内持续。建议将头孢曲松和阿奇霉素的双重治疗作为治疗淋病的一线方案。世卫组织建议对有症状和无症状淋病患者进行双重治疗而不是单一治疗。此外,单一疗法在全球许多环境中不再是可行的选择。此外,不断提高的公众意识和庞大的患者群体也促进了淋病治疗市场的增长。

Gonorrhea Therapeutics Market

竞争格局

淋病治疗市场在与少数主要制药公司的竞争方面得到巩固。淋病治疗市场的一些主要参与者包括 Allergan, Inc.、F. Hoffmann-La Roche Ltd、GlaxoSmithKline plc、Lupin Pharmaceuticals、Pfizer Inc、Teligent, Inc. 等。

主要玩家

  1. Allergan, Inc.

  2. F. Hoffmann-La Roche Ltd

  3. GlaxoSmithKline plc

  4. Lupin Pharmaceuticals, Inc.

  5. Pfizer Inc.

*Disclaimer: Major Players sorted in no particular order

Gonorrhea Therapeutics Market

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Growing Burden of Gonorrhea

      2. 4.2.2 Growing Government and Private Sector Participation Through National Campaigns

    3. 4.3 Market Restraints

      1. 4.3.1 Stringent Regulatory Scenario

      2. 4.3.2 Social Stigma Associated With Patients Visiting STD Clinics

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Gonococcal Infection

      1. 5.1.1 Uncomplicated Gonococcal Infection

      2. 5.1.2 Gonococcal Arthritis

      3. 5.1.3 Gonococcal Meningitis and Endocarditis

    2. 5.2 By Treatment

      1. 5.2.1 Monotherapy

      2. 5.2.2 Dual Therapy

    3. 5.3 By End User

      1. 5.3.1 Hospital Pharmacies

      2. 5.3.2 Retail Pharmacies

      3. 5.3.3 Online Pharmacies

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany

        2. 5.4.2.2 United Kingdom

        3. 5.4.2.3 France

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Middle-East & Africa

        1. 5.4.4.1 GCC

        2. 5.4.4.2 South Africa

        3. 5.4.4.3 Rest of Middle-East and Africa

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil

        2. 5.4.5.2 Argentina

        3. 5.4.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Allergan, Inc.

      2. 6.1.2 F. Hoffmann-La Roche Ltd

      3. 6.1.3 GlaxoSmithKline plc

      4. 6.1.4 Lupin Pharmaceuticals

      5. 6.1.5 Pfizer Inc.

      6. 6.1.6 Teligent, Inc.

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

淋病治疗市场的研究时间为 2018 年至 2028 年。

未来 5 年,淋病治疗市场的复合年增长率为 3.5%。

亚太地区在 2018 年至 2028 年期间的复合年增长率最高。

北美在 2021 年的份额最高。

Allergan, Inc.、F. Hoffmann-La Roche Ltd、GlaxoSmithKline plc、Lupin Pharmaceuticals, Inc.、Pfizer Inc. 是在淋病治疗市场运营的主要公司。

close-icon
80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!